Our history

Since its creation in 2000, Inserm Transfert has been continuously discovering innovations from the Inserm laboratories and developing them among industrialists.

Our history

It was in 1980 when the Bayh-Dole Act in the United States opened the path to the creation of a value creation office and TTO (Technology Transfer Office). France followed two years later with the “guiding and programming law for technological research and development”: this introduced the principals of value creation and researchers being an objective on a similar scale to that of knowledge acquisition. In 1984 the law on higher education, strengthened the 1982 law enabling the formation of value creation departments within Universities.

In 1999, the Allègre law made it possible for universities and researchers to create a start-up and to submit patents.

Following this last law, Inserm decided, in 2000, to create Inserm Transfert. The company has advanced in a rich, stimulating and complex human health innovation ecosystem at the interface between the academic and industrial world and with local, national and international components.

  • 2000

    Creation of Inserm Transfert, the private subsidiary of Inserm

  • 2003

    Creation of a dedicated team helping researchers to respond to EU collaborative research projects calls

  • 2005

    Creation of Inserm Transfert Initiative, a dedicated seed money fund for life sciences

  • 2006

    Inserm Transfert has been given the management of the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation

  • 2009

    Inserm creates a proof of concept investment fund entirely managed by Inserm Transfert

  • 2010 - 2012

    Inserm Transfert is ISO 9001:2008 certified for its European and international project management activities and its intellectual Property activity

  • 2015

    Definition and setting up of a strategic road map Inserm Transfert 2020: In parallel to the strategic plan Inserm 2020

  • 2017

    Inserm Transfert has launched in 2017 this Pathway for Pre-entrepreneurship to support researchers/inventors that aspire to become involved in entrepreneurship and to help them become ”Enlighted founders” (“Fondateurs Eclairés”)

  • 2018

    Inserm Transfert is ISO 9001 v 2015 certified for all its technology transfer activities. Set up of the strategic road map from Inserm Transfert "FRS 2018-2028"

  • 2019

    Inserm Transfert is a well-recognized company worldwide in economic and societal value creation in human health. Laureate of French Tech Seed with the HHSF Consortium (Human Health Startup Factory)

  • 2020

    Inserm Transfert is 20 years old. Inserm Transfert maintains ISO 9001 v2015 certification for the quality management of all its activities. Inserm Transfert co-constructs the PBS Consortium Laureate of 2nd call for proposals SIA "SATT-Incubators-Accelerators" from Investments for the future program (PIA)

  • 2021

    New strategic road map Inserm Transfert 2021-2025

  • 2022

    Inserm Transfert maintains ISO 9001 v 2015 certificate for all its technology transfer activities.

Paris Biopark - 7 Rue Watt, 75013 Paris - France
Tel : (+33)1 55 03 01 00

Privacy | Terms | ©2022 Inserm Transfert